Event Date/Time: Nov 12, 2003
End Date/Time: Nov 14, 2003
IBC's 8th Well Characterized Biologicals conference continues to serve as a leading resource for industry representatives seeking updates on current analytical technologies and regulatory policies surrounding highly characterized biological therapeutics. The first presentation of the main conference is a rare keynote address on Immunogencity of Biological Therapeutics and Potential Approaches to Tolerance Induction by Amy Rosenberg, M.D., Director of the Division of Therapeutic Proteins, CDER, US, FDA. Your attendance will ensure comprehensive knowledge of the most recent changes in FDA perspectives. By attending Well Characterized Biologicals you will be able to implement vanguard techniques to obtain rapid possible approval of your biological. Benefit from the programming that will best meet your needs by adding on up for the short course on Immunogenicity. Reserve your space and register today. Detailed abstracts and registration information available are online at www.LifeSciencesInfo.com/WCB.